Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Chest pain? 588 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 588 reports of Chest pain have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.5% of all adverse event reports for CYCLOPHOSPHAMIDE.

588
Reports of Chest pain with CYCLOPHOSPHAMIDE
0.5%
of all CYCLOPHOSPHAMIDE reports
73
Deaths
359
Hospitalizations

How Dangerous Is Chest pain From CYCLOPHOSPHAMIDE?

Of the 588 reports, 73 (12.4%) resulted in death, 359 (61.1%) required hospitalization, and 30 (5.1%) were considered life-threatening.

Is Chest pain Listed in the Official Label?

Yes, Chest pain is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Chest pain?

ADALIMUMAB (5,033) TREPROSTINIL (3,495) RITUXIMAB (3,155) METHOTREXATE (3,104) PREDNISONE (2,985) ETANERCEPT (2,765) INFLIXIMAB (2,636) AMBRISENTAN (2,575) TOCILIZUMAB (2,288) TOFACITINIB (2,284)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Chest pain Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Chest pain Reports All Drugs Causing Chest pain CYCLOPHOSPHAMIDE Demographics